Mallinckrodt plc

Track this case

Case overview

Case Number:

1:20-bk-12522

Court:

Delaware

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

October 18, 2022
Mallinckrodt Trust Sues To Recover $1.6B Share Buyback

A litigation trust formed under opioid distributor Mallinckrodt PLC's now-confirmed Delaware Chapter 11 has sued to claw back proceeds from nearly $1.6 billion in pre-bankruptcy share repurchases, carried out as the company's liability for the opioid epidemic swamped its total worth.
October 14, 2022
Alex Jones' Billion-Dollar Penance, Puerto Rico Prunes Debt

Conspiracy theorist Alex Jones' podcast company is headed toward Chapter 11 mediation after a $965 million defamation damages judgment, Puerto Rico takes another step in restructuring the island's public debt, and the U.S. Supreme Court remanded issues over an increase in trustee fees to the Second Circuit. This is the week in bankruptcy.
October 13, 2022
Mallinckrodt Ch. 11 Trustee Settles Acthar Royalty Claims

The trustee administering the claims of general unsecured creditors under the confirmed plan of drugmaker Mallinckrodt PLC asked a Delaware bankruptcy court for approval Wednesday of a settlement that would resolve royalty claims associated with the company's Acthar gel.
June 08, 2022
Costlier Loans Clear Mallinckrodt For Ch. 11 Exit Next Week

Bankrupt drugmaker Mallinckrodt PLC reported Wednesday that its Chapter 11 plan would most likely take effect on June 14, after the eleventh-hour approval of a $650 million exit financing package that replaced — at much higher cost — a $900 million exit financing agreement.
May 23, 2022
Mallinckrodt Calls Shareholder Ch. 11 Stay Bid Untimely

Drugmaker Mallinckrodt PLC objected Monday to a motion from an equity holder seeking to stay the consummation of the company's Chapter 11 plan pending the outcome of an appeal of a claims bar date decision, saying the stay motion came months late and after other, more targeted stay requests were defeated.
April 25, 2022
Mallinckrodt Creditors Can't Get Ch. 11 Plan Halted

Unsecured creditors of drugmaker Mallinckrodt PLC have lost their bid to delay the effective date of the company's Chapter 11 plan in Delaware federal court, with a Third Circuit judge saying the creditors had not shown they would be irreparably harmed if the plan is consummated.
March 24, 2022
Mallinckrodt Creditor Payments Won't Be Held For Appeals

A Delaware bankruptcy judge Thursday denied requests to hold distributions from drugmaker Mallinckrodt's Chapter 11 plan while appeals of how the funds are being divided up are pending, saying it is likely the appeals will be heard before the money goes out.
March 01, 2022
Acthar Claimants Seek End To Mallinckrodt Litigation Pause

A group of Acthar gel tort claimants asked a Delaware bankruptcy judge on Tuesday to reject a request by Mallinckrodt to continue an order pausing Acthar suits, saying there is no longer a "legal or practical" reason to hold up their claims against a third party.
February 14, 2022
Mallinckrodt Seeks Last Extension Of Ch. 11 Acthar Suit Pause

Mallinckrodt PLC is asking a Delaware bankruptcy judge for one final extension of an order pausing lawsuits against the drugmaker relating to its marketing of Acthar gel products, saying it needs the injunction to see it through to the end of its Chapter 11 case.
February 04, 2022
Mallinckrodt Ch. 11 Plan Gets Green Light From Del. Court

A Delaware federal bankruptcy court on Thursday confirmed Mallinckrodt PLC's Chapter 11 plan, which the drugmaker said reduces the company's total debt by approximately $1.3 billion.